BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6410549)

  • 1. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
    Lasky LC; Warkentin PI; Kersey JH; Ramsay NK; McGlave PB; McCullough J
    Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation.
    Araújo AB; Schmalfuss T; Furlan JM; Speransa D; Angeli MH; Sekine L; Franz JPM
    Cytotherapy; 2024 May; ():. PubMed ID: 38795114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Rate of Passenger Lymphocyte Syndrome after ABO Minor Incompatible Lung Transplantation.
    Kohl MM; Schwarz S; Jaksch P; Muraközy G; Kurz M; Schönbacher M; Tolios A; Frommlet F; Hoetzenecker K; Körmöczi GF
    Am J Respir Crit Care Med; 2024 Apr; 209(8):995-1000. PubMed ID: 38078854
    [No Abstract]   [Full Text] [Related]  

  • 4. Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.
    Özen M; Yılmaz S; Özkan T; Özer Y; Pekel AA; Sunguroğlu A; Gürman G; Arslan Ö
    Turk J Haematol; 2018 Mar; 35(1):54-60. PubMed ID: 28533197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passenger lymphocyte syndrome following minor ABO-mismatched liver transplantation.
    Mathavan A; Krekora U; Kleehammer AC; Mathavan A
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38453222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of ABO minor incompatible platelets transfusions using a rapid infuser.
    Jung Y; Luo O; Sen N; Li FM; Hasan RA; Hess AS; Hess JR; Sabath DE; Tsang HC; Pagano MB
    Transfusion; 2024 Mar; 64(3):449-453. PubMed ID: 38299721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.
    Kopko PM
    Transfus Med Hemother; 2016 Jan; 43(1):13-8. PubMed ID: 27022318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies.
    Ramsey G; Cornell FW; Hahn LF; Fonzi F; Starzl TE
    Transplant Proc; 1989 Jun; 21(3):3531. PubMed ID: 2500759
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic strategies for acute hemolysis secondary to plasma-incompatible platelet transfusions: correlation between qualitative hemolysin test and isohemagglutinin titration.
    Landim CS; Gomes FC; Zeza BM; Mendrone-Júnior A; Dinardo CL
    Rev Bras Hematol Hemoter; 2015; 37(4):217-22. PubMed ID: 26190423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Heart Transplantation Despite Rhesus Blood Type Mismatch: A Case Report.
    Kim JH; Shin YR
    J Chest Surg; 2024 Mar; 57(2):217-219. PubMed ID: 38057953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic experience of a combined ABO- and Rh-incompatible living donor liver transplantation between an O Rh- recipient and a B Rh+ donor.
    Choi J; Seo H; Jeong SM; Hwang GS
    Korean J Anesthesiol; 2013 Nov; 65(5):480-1. PubMed ID: 24363857
    [No Abstract]   [Full Text] [Related]  

  • 12. Red Blood Cell Membrane-Coated Nanoparticles Enable Incompatible Blood Transfusions.
    Yang X; Chen M; Weng C; Zhuge D; Jin F; Xiao Y; Tian D; Yin Q; Li L; Zhang X; Shi G; Lu X; Yan L; Wang L; Wen B; Zhao Y; Lin J; Wang F; Zhang W; Chen Y
    Adv Sci (Weinh); 2024 Jun; ():e2310230. PubMed ID: 38837643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides.
    Shokrgozar N; Tamaddon G
    Int J Hematol Oncol Stem Cell Res; 2018 Oct; 12(4):322-328. PubMed ID: 30774834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO Incompatibility and Hematopoietic Stem Cell Transplantation Outcomes.
    Vaezi M; Oulad Dameshghi D; Souri M; Setarehdan SA; Alimoghaddam K; Ghavamzadeh A
    Int J Hematol Oncol Stem Cell Res; 2017 Apr; 11(2):139-147. PubMed ID: 28875009
    [No Abstract]   [Full Text] [Related]  

  • 15. Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes.
    Cid J; Lozano M; Klein HG; Flegel WA
    Blood Transfus; 2014 Jul; 12(3):301-6. PubMed ID: 24887231
    [No Abstract]   [Full Text] [Related]  

  • 16. The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when.
    Daniele N; Scerpa MC; Rossi C; Lanti A; Adorno G; Isacchi G; Zinno F
    Blood Transfus; 2014 Apr; 12(2):150-8. PubMed ID: 24333081
    [No Abstract]   [Full Text] [Related]  

  • 17. The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation.
    Vande Vusse LK; Madtes DK; Guthrie KA; Gernsheimer TB; Curtis JR; Watkins TR
    Transfusion; 2014 Apr; 54(4):1071-80. PubMed ID: 24033082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell and gene therapies: moving from research to clinic.
    Stroncek DF; Puri RK
    J Transl Med; 2010 Mar; 8():31. PubMed ID: 20350323
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.
    Stussi G; Halter J; Bucheli E; Valli PV; Seebach L; Gmür J; Gratwohl A; Schanz U; Passweg JR; Seebach JD
    Haematologica; 2009 Feb; 94(2):239-48. PubMed ID: 19144657
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.